Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Diagnostics Analytical science, Oncology, Technology and innovation

Two Is Better Than One for Precision Tissue Sampling

Cancer diagnostics are advancing rapidly, but for patients with high-grade serous ovarian cancer (HGSOC) – in which high genomic heterogeneity is common and associated with reduced progression-free survival – disease stratification needs a major overhaul.

A multidisciplinary team at the Cancer Research UK Cambridge Centre – with expertise in radiology, physics, oncology, and computer science – previously found that computed tomography (CT) scans can show high heterogeneity of HGSOC lesions that indicate different molecular profiles (1). “To study this relationship further, we needed to be able to selectively sample the regions – or ‘habitats’ – of interest, which requires imaging guidance,” says Mireia Crispin-Ortuzar, a researcher on the study. “However, habitats are extracted on CT scans, whereas biopsies are most commonly obtained using ultrasound guidance. This prompted us to develop a technique to target ovarian cancer habitats using CT-ultrasound fusion.”

The team used radiomics to spatially identify the habitats from the CT scans, then superimposed the maps onto CT images and co-registered them with ultrasound images to guide biopsies (2). In doing so, they successfully captured the diverse range of cancer cells within the tumors – leading to a more accurate biopsy.

Though a tremendous step forward for the research community, those who feel it most will be the patients. “When you are first undergoing the diagnosis of cancer, you feel as if you are on a conveyor belt – every part of the journey being extremely stressful,” said Fiona Barve (3), who was diagnosed with stage four ovarian cancer in 2017. “This new, enhanced technique will reduce the need for several procedures and allow patients more time to adjust to their circumstances. It will enable more accurate diagnosis with less invasion of the body and mind. This can only be seen as positive progress.”

So what’s next for the team? “The technique enables us to obtain tissue samples that are accurately matched to regions of well-defined characteristics on CT scans,” says Crispin-Ortuzar. “We plan to explore the correlation between imaging parameters and tumor biology dynamically – at different points during treatment. This will form the foundation for a more strategic, targeted approach to ovarian cancer biopsies.”

Subscribe to The Pathologist Newsletters

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].

  1. L Rundo et al., Comput Biol Med, 120, 103751 (2020). PMID: 32421652.
  2. L Beer et al., Eur Radiol, [Online ahead of print] (2020). PMID: 33315123.
  3. University of Cambridge (2021). Available at: http://bit.ly/2MqC9vT.

About the Author

Olivia Gaskill

During my undergraduate degree in psychology and Master’s in neuroimaging for clinical and cognitive neuroscience, I realized the tasks my classmates found tedious – writing essays, editing, proofreading – were the ones that gave me the greatest satisfaction. I quickly gathered that rambling on about science in the bar wasn’t exactly riveting for my non-scientist friends, so my thoughts turned to a career in science writing. At Texere, I get to craft science into stories, interact with international experts, and engage with readers who love science just as much as I do.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register